Abstract:beta-Arrestins are key negative regulators and scaffolds of G protein-coupled receptor (GPCR) signalling. beta-Arrestin1 and beta-arrestin2 preferentially bind to the phosphorylated GPCRs in response to agonist stimulation, resulting in receptor internalization and desensitization. The critical roles of GPCR kinases (GRKs)-catalyzed receptor phosphorylation and interaction of beta-arrestins with the phosphorylated receptor in receptor internalization are well established. However, emerging evidence suggests that an agonist-stimulated internalization mechanism that is independent of receptor phosphorylation may also be employed in some cases, although the molecular mechanism for the phosphorylation-independent GPCR internalization is not clear. The current study investigated the role of receptor phosphorylation and the involvement of different beta-arrestin subtypes in agonist-induced delta-opioid receptor (DOR) internalization in HEK293 cells. Results from flow cytometry, fluorescence microscopy, and surface biotin labelling experiments showed that elimination of agonist-induced DOR phosphorylation by mutation GRK binding or phosphorylation sites only partially blocked agonist-induced receptor internalization, indicating the presence of an agonist-induced, GRK-independent mechanism for DOR internalization. Fluorescence and co-immunoprecipitation studies indicated that both the wild-type DOR and the phosphorylation-deficient mutant receptor could bind and recruit beta-arrestin1 and beta-arrestin2 to the plasma membrane in an agonist-stimulated manner. Furthermore, internalization of both the wild-type and phosphorylation-deficient receptors was increased by overexpression of either type of beta-arrestins and blocked by dominant-negative mutants of beta-arrestin-mediated internalization, demonstrating that both phosphorylation-dependent and -independent internalization require beta-arrestin. Moreover, double-stranded RNA-mediated interference experiments showed that either beta-arrestin1 or beta-arrestin2 subtype-specific RNAi only partially inhibited agonist-induced internalization of the wild-type DOR. However, agonist-induced internalization of the phosphorylation-deficient DOR was not affected by beta-arrestin1-specific RNAi but was blocked by RNAi against beta-arrestin2 subtype. These data indicate that endogenous beta-arrestin1 functions exclusively in the phosphorylation-dependent receptor internalization, whereas endogenous beta-arrestin2, but not beta-arrestin1, is required for the phosphorylation-independent receptor internalization. These results thus provide the first evidence of different requirement for beta-arrestin isoforms in the agonist induced phosphorylation-dependent and -independent GPCR internalization.

Direct binding of β-arrestins to two distinct intracellular domains of the δ opioid receptor: Interaction of δ opioid receptor with β-arrestins

Direct binding of β-arrestins to two distinct intracellular domains of the δ opioid receptor

Direct and Differential Interaction of β-Arrestins with the Intracellular Domains of Different Opioid Receptors

Direct and Differential Interaction of Beta-Arrestins with the Intracellular Domains of Different Opioid Receptors.

β-Arrestin1 and β-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of δ-opioid receptors: Roles of phosphorylation and different β-arrestins in DOR endocytosis

REGULATION OF OPIOID RECEPTOR SIGNAL TRANSDUCTION VIA BETA-ARRESTINS

Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.

Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of Δ-Opioid Receptor at Serine 344, Resulting in Β-Arrestin- and Clathrin-mediated Receptor Internalization

Molecular Modeling on Kappa Opioid Receptor and Its Interaction with Nonpeptide Kappa Opioid Agonists

Structural Basis for Bifunctional Peptide Recognition at Human Δ-Opioid Receptor

Differential regulation of β-arrestin 1 and β-arrestin 2 gene expression in rat brain by morphine

Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.

Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators

Post‐endocytic Fates of Δ‐opioid Receptor Are Regulated by GRK2‐mediated Receptor Phosphorylation and Distinct Β‐arrestin Isoforms

Determination of structural factors affecting binding to mu, kappa and delta opioid receptors

Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of delta-opioid receptors.

How Does Agonist and Antagonist Binding Lead to Different Conformational Ensemble Equilibria of the κ-Opioid Receptor: Insight from Long-Time Gaussian Accelerated Molecular Dynamics Simulation

Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated δ-opioid receptor phosphorylation

Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray.

Single-molecule detection of transient dimerization of opioid receptors 1: Homodimers' effect on signaling and internalization

Different stimulatory opioid effects on intracellular Ca(2+) in SH-SY5Y cells.